Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
A one-year follow-up study of the Symbol Digit Modalities Test (SDMT) and the Paced Auditory Serial Addition Test (PASAT) in relapsing-remitting multiple sclerosis: an appraisal of comparative longitudinal sensitivity.
Initiating oral fingolimod treatment in patients with multiple sclerosis.
[The quality of nighttime sleep in patients with multiple sclerosis].
Home-based palliative approach for people with severe multiple sclerosis and their carers: study protocol for a randomized controlled trial.
The clinico-radiological paradox in multiple sclerosis: novel implications of lesion size.
Stem cell-based therapies for multiple sclerosis: recent advances in animal models and human clinical trials.
Effects of vitamin D on immune disorders with special regard to asthma, COPD and autoimmune diseases: a short review.
Reliability and Validity of PROMIS Cognitive Abilities and Cognitive Concerns Scales Among People with Multiple Sclerosis.
Restless legs syndrome and multiple sclerosis: a population based case-control study in Catania, Sicily.
Multiple Sclerosis from Bench to Bedside.
(18)F-fluoroethyl-L-tyrosine positron emission tomography for the differential diagnosis of tumefactive multiple sclerosis versus glioma: A case report.
Tumefactive multiple sclerosis lesions under fingolimod treatment.
Alemtuzumab and multiple sclerosis: Is it safe?
Prevalence of multiple sclerosis in Al Quseir city, Red Sea Governorate, Egypt.
Neuroimmunology: Cyclosporine A and azathioprine are effective adjunctive treatments for neuromyelitis optica.
Impact of simulated microgravity on oligodendrocyte development: implications for central nervous system repair.
Missing links in multiple sclerosis etiology. A working connecting hypothesis.
Neuromyelitis optica.
Molecular triggers of neuroinflammation in mouse models of demyelinating diseases.
Molecular grafting onto a stable framework yields novel cyclic peptides for the treatment of multiple sclerosis.
Multiple sclerosis: the role of cytokines in pathogenesis and in therapies.
Multiple Sites of the Cleavage of 21- and 25-Mer Encephalytogenic Oligopeptides Corresponding to Human Myelin Basic Protein (MBP) by Specific Anti-MBP Antibodies from Patients with Systemic Lupus Erythematosus.
Randomized controlled trial of a behavioral intervention targeting symptoms and physical activity in multiple sclerosis.
Preventive and Therapeutic Effects of Adenanthin on Experimental Autoimmune Encephalomyelitis by Inhibiting NF-κB Signaling.
Transverse myelitis following combined spinal-epidural anesthesia.
Pages
« first
‹ previous
…
289
290
291
292
293
294
295
296
297
…
next ›
last »